Phyllodes tumors and breast sarcomas: a review

被引:9
|
作者
Grenier, J. [1 ]
Delbaldo, C. [2 ]
Zelek, L. [3 ]
Piedbois, P. [4 ]
机构
[1] Inst St Catherine, F-84082 Avignon 02, France
[2] CHU Henri Mondor, Med Oncol Serv, F-94000 Creteil, France
[3] CHU Avicenne, Med Oncol Serv, F-93009 Bobigny, France
[4] AstraZeneca, Serv Rech Clin, F-92844 Rueil Malmaison, France
关键词
phyllodes tumors; primary breast sarcoma; angiosarcomas chemotherapy; SOFT-TISSUE SARCOMAS; PRIMARY OSTEOGENIC-SARCOMA; CYSTOSARCOMA-PHYLLODES; HISTOLOGIC FEATURES; DISTANT METASTASES; SURGICAL-TREATMENT; LOCAL RECURRENCE; ANGIOSARCOMA; THERAPY; GRADE;
D O I
10.1684/bdc.2010.1174
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Phyllodes tumors and sarcomas of the breast are non-epithelial tumors of the breast. Phyllodes tumors are benign tumors, tumors of intermediate malignancy or malignant tumors. The differential diagnosis with a very proliferant fibroadenoma may be difficult. Histological subtype, type of surgery (definitive or not) and stromal proliferation determine the prognosis. There is a risk of local relapse and distant metastases, in particular to the lung. Surgery (often radical) is the standard treatment. Radiotherapy is recommended in case of high-grade tumor and after conservative-treatment. Breast sarcomas are even rarer. All histological types exist with a predominance of histiofibrocytome type tumors. Grade, involved margins and sometimes tumor necrosis are major prognostics factors. Among the various sub-types, angiosarcoma is characterized by a high risk of occurrence in irradiated fields and by a poor prognosis with a high risk of lung metastases. The treatment is mostly based on mastectomy without lymph node dissection given the exceptional flooding axillary. In some situations, a conservative treatment can be discussed, based on tumor size, grade and volume of the breast. Locoregional radiotherapy is often proposed for tumors over 5 cm and/or of high grade. Systemic chemotherapy is not a standard but should be discussed in the forms at high risk of relapse (like angiosarcoma).
引用
收藏
页码:1197 / 1207
页数:11
相关论文
共 50 条
  • [41] Genomic profile of breast sarcomas: a comparison with malignant phyllodes tumours
    Lim, Sue Zann
    Ng, Cedric Chuan Young
    Rajasegaran, Vikneswari
    Guan, Peiyong
    Selvarajan, Sathiyamoorthy
    Thike, Aye Aye
    Nasir, Nur Diyana Binte Md
    Koh, Valerie Cui Yun
    Tan, Benita Kiat Tee
    Ong, Kong Wee
    Teh, Bin Tean
    Tan, Puay Hoon
    BREAST CANCER RESEARCH AND TREATMENT, 2019, 174 (02) : 365 - 373
  • [42] Malignant phyllodes tumor and primary breast sarcoma; distinct rare tumors of the breast
    Gutnik, Lily
    Ren, Yi
    Thomas, Samantha M.
    Plichta, Jennifer K.
    Greenup, Rachel A.
    Fayanju, Oluwadamilola M.
    Hwang, E. Shelley
    Rosenberger, Laura H.
    JOURNAL OF SURGICAL ONCOLOGY, 2022, 125 (06) : 947 - 957
  • [43] Local Recurrent Phyllodes Tumors of the Breast Clinical and Sonographic Features
    Xiao, Mengsu
    Zhu, Qingli
    Jiang, Yuxin
    Li, Jianchu
    Wang, Hongyan
    Zhang, Jing
    You, Shanshan
    Liu, He
    JOURNAL OF ULTRASOUND IN MEDICINE, 2015, 34 (09) : 1631 - 1638
  • [44] Management of malignant phyllodes tumors of the breast: The experience of the Institut Curie
    Haberer, S.
    Lae, M.
    Seegers, V.
    Pierga, J. -Y.
    Salmon, R.
    Kirova, Y. M.
    Dendale, R.
    Campana, F.
    Reyal, F.
    Miranda, O.
    Fourquet, A.
    Bollet, M. -A.
    CANCER RADIOTHERAPIE, 2009, 13 (04): : 305 - 312
  • [45] IMP3 Is Strongly Expressed in Malignant Phyllodes Tumors of the Breast: An Immunohistochemical Study
    Bellezza, Guido
    Prosperi, Enrico
    Del Sordo, Rachele
    Colella, Renato
    Rulli, Antonio
    Sidoni, Angelo
    INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY, 2016, 24 (01) : 37 - 42
  • [46] Surgery for phyllodes tumors of the breast: Is the denomination of a giant phyllodes tumor justified?
    Amavi, A. K. A.
    Lamboni, D.
    Dossouvi, T.
    Sakiye, A.
    Alassani, A.
    Adabra, A.
    ANNALES DE CHIRURGIE PLASTIQUE ESTHETIQUE, 2025, 70 (02): : 85 - 89
  • [47] Clinical outcomes and biomarkers of phyllodes tumors of the breast: A single-center retrospective study
    Chen, Keyu
    Xu, Jiaojiao
    Wang, Wei
    Jiang, Ruiyuan
    Zhang, Huanping
    Wang, Xiaojia
    Cao, Jun
    Fang, Meiyu
    CANCER MEDICINE, 2023, 12 (10): : 11363 - 11374
  • [48] Is the extent of surgical resection important in patient outcome in benign and borderline phyllodes tumors of the breast?
    Sevinc, Ali Ibrahim
    Aksoy, Sleyman Ozkan
    Durak, Merih Guray
    Balci, Pinar
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2018, 48 (01) : 28 - 33
  • [49] Clinicopathologic Risk Factors for the Local Recurrence of Phyllodes Tumors of the Breast
    Jang, Jae Hyuck
    Choi, Min-Young
    Lee, Se Kyung
    Kim, Sangmin
    Kim, Jiyoung
    Lee, Jeonghui
    Jung, Seung Pil
    Choe, Jun-Ho
    Kim, Jung-Han
    Kim, Jee Soo
    Cho, Eun Yoon
    Lee, Jeong Eon
    Nam, Seok Jin
    Yang, Jung-Hyun
    ANNALS OF SURGICAL ONCOLOGY, 2012, 19 (08) : 2612 - 2617
  • [50] Management of malignant and borderline phyllodes tumors of the breast: our experience
    Zervoudis, Stefanos
    Xepapadakis, Grigoris
    Psarros, Nikos
    Bothou, Anastasia
    Tsikouras, Panagiotis
    Galazios, Georgios
    Kontogianni, Panagiota
    Papazian, Maria
    Navrozoglou, Iordanis
    Iatrakis, Georgios
    Paschopoulos, Minas
    JOURNAL OF BUON, 2019, 24 (04): : 1521 - 1525